Patents/Assignees

Diacarta Inc.

1 patent in portfolio

US11845934utility2023
Specific Synthetic Chimeric Xenonucleic Acid Guide RNA; S(xna-grna) for Enhancing CRISPR Mediated Genome Editing Efficiency
0 cites